Kinase-inactivated CDK6 preserves the long-term functionality of adult hematopoietic stem cells
Blood · 11.07.2024 · 144 (2) · 156-170
DOI: 10.1182/blood.2023021985 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood, erschienen am 11.07.2024. Verfasst von Isabella M Mayer und 19 weiteren Autor:innen. Beteiligte Einrichtung: University of Veterinary Medicine, Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinase 6, Hematopoietic Stem Cells. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Hematopoietic stem cells (HSCs) are characterized by the ability to self-renew and to replenish the hematopoietic system. The cell-cycle kinase cyclin-dependent kinase 6 (CDK6) regulates transcription, whereby it has both kinase-dependent and kinase-independent functions. Herein, we describe the complex role of CDK6, balancing quiescence, proliferation, self-renewal, and differentiation in activated HSCs. Mouse HSCs expressing kinase-inactivated CDK6 show enhanced long-term repopulation and homing, whereas HSCs lacking CDK6 have impaired functionality. The transcriptomes of basal and serially transplanted HSCs expressing kinase-inactivated CDK6 exhibit an expression pattern dominated by HSC quiescence and self-renewal, supporting a concept, in which myc-associated zinc finger protein (MAZ) and nuclear transcription factor Y subunit alpha (NFY-A) are critical CDK6 interactors. Pharmacologic kinase inhibition with a clinically used CDK4/6 inhibitor in murine and human HSCs validated our findings and resulted in increased repopulation capability and enhanced stemness. Our findings highlight a kinase-independent role of CDK6 in long-term HSC functionality. CDK6 kinase inhibition represents a possible strategy to improve HSC fitness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Veterinary Medicine, Vienna, Vienna, Austria.
- Institute of Pharmaceutical Sciences, Pharmaceutical Chemistry, University of Graz, Graz, Austria.
- Department of Dermatology, Medical University of Vienna, Vienna, Austria.
- Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.
- Clinical Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
- Institute of Pharmacology, Centre of Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Isabella M Mayer, Eszter Doma, Thorsten Klampfl, Sebastian Kollmann, Alessia Schirripa, Lisa E Shaw, Alex Farr, Matthias Farlik, Karoline Kollmann
Zitieren
APA
Mayer, I. M., Doma, E., Klampfl, T., Prchal-Murphy, M., Kollmann, S., Schirripa, A., Scheiblecker, L., Zojer, M., Kunowska, N., Gebrail, L., Shaw, L. E., Mann, U., Farr, A., Grausenburger, R., Heller, G., Zebedin-Brandl, E., Farlik, M., Malumbres, M., Sexl, V., & Kollmann, K. (2024). Kinase-inactivated CDK6 preserves the long-term functionality of adult hematopoietic stem cells. Blood, 144(2), 156-170. https://doi.org/10.1182/blood.2023021985
Vancouver
Mayer IM, Doma E, Klampfl T, Prchal-Murphy M, Kollmann S, Schirripa A, et al. Kinase-inactivated CDK6 preserves the long-term functionality of adult hematopoietic stem cells. Blood. 2024;144(2):156-170. doi:10.1182/blood.2023021985
BibTeX
@article{Mayer2024,
author = {Mayer, Isabella M and Doma, Eszter and Klampfl, Thorsten and Prchal-Murphy, Michaela and Kollmann, Sebastian and Schirripa, Alessia and Scheiblecker, Lisa and Zojer, Markus and Kunowska, Natalia and Gebrail, Lea and Shaw, Lisa E and Mann, Ulrike and Farr, Alex and Grausenburger, Reinhard and Heller, Gerwin and Zebedin-Brandl, Eva and Farlik, Matthias and Malumbres, Marcos and Sexl, Veronika and Kollmann, Karoline},
title = {Kinase-inactivated CDK6 preserves the long-term functionality of adult hematopoietic stem cells},
journal = {Blood},
year = {2024},
volume = {144},
number = {2},
pages = {156--170},
doi = {10.1182/blood.2023021985}
}
EUVIMED